Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study

Figure 3

Kaplan-Meyer plot of cumulative proportion of patients remaining free from Expanded Disability Status Scale (EDSS) progression over time from start of fingolimod therapy.